F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast enhanced MRI
Open Access
- 31 March 2012
- journal article
- research article
- Published by Elsevier BV in European Journal of Radiology
- Vol. 81 (3), 508-513
- https://doi.org/10.1016/j.ejrad.2011.01.080
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The role of advanced MR imaging in understanding brain tumour pathologyBritish Journal Of Neurosurgery, 2007
- FDG-PET on irradiated brain tumor: ten years' summaryActa Radiologica, 2006
- Positron emission tomography imaging of brain tumorsNeuroimaging Clinics Of North America, 2002
- Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumorsJournal of Neurosurgery, 1999
- Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PETJournal of the Neurological Sciences, 1995
- Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.Radiology, 1995
- Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytomaInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Brain radiation lesions: MR imaging.Radiology, 1986
- Glucose utilization of cerebral gliomas measured by [ 18 F] fluorodeoxyglucose and positron emission tomographyNeurology, 1982
- Radiation Necrosis of the BrainJournal of Computer Assisted Tomography, 1978